Organization
Sarepta Therapeutics, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Sarepta Therapeutics, Inc.
... shareholders of Morgan Stanley (NYSE:MS), Novavax, Inc. (NASDAQ:NVAX), Xerox Corporation (NYSE:XRX), Sarepta Therapeutics, Inc. (NASDAQ:SRPT), Semgroup Corporation (NYSE:SEMG), and Toll Brothers Inc. (NYSE:TOL), including updated ...
... research to the investment community. Today we are offering reports on SAGE, SRPT, SRRA, and SRNE which can be accessed for free by signing up ...
... CAMBRIDGE - Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... CAMBRIDGE, Mass., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... CAMBRIDGE - Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... ever-changing industry. Included in today's commentary: Propanc Biopharma, Inc.(OTC: PPCB, Sarepta Therapeutics, Inc. (NASDAQ: SRPT), ImmunoGen, Inc. (NASDAQ: IMGN), PTC Therapeutics, Inc. (NASDAQ: PTCT), and ...
... over a decade of research a gratifying experience." Last year, Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... SAN FRANCISCO - Sarepta Therapeutics, Inc.(NASDAQ: SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... CAMBRIDGE - Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... CAMBRIDGE, Mass., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... CAMBRIDGE, Mass., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... CAMBRIDGE, Mass., Dec. 27, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... with timely information, WallStEquities.com has issued free tailored Stock Review on PTLA, SRPT, PACB, and BLUE which is a click away athttp://www.wallstequities.com/registration. Research coverage has ...
... of a $22.0 million (£17.2 million) development milestone payment received from Sarepta Therapeutics Inc. (-Sarepta') in June 2017. This announcement contains inside information for the ...
... CAMBRIDGE, Mass., Dec. 05, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... on Monday to revive their securities class action claiming executives at Sarepta Therapeutics Inc. selectively omitted facts and misled investors in 2014 about the clinical ...
... CAMBRIDGE - Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... CAMBRIDGE, Mass., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... shareholders of Morgan Stanley (NYSE:MS), TripAdvisor, Inc. (NASDAQ:TRIP), Xerox Corporation (NYSE:XRX), Sarepta Therapeutics, Inc. (NASDAQ:SRPT), Semgroup Corporation (NYSE:SEMG), and Toll Brothers Inc. (NYSE:TOL), including updated ...
... CAMBRIDGE, Mass. - Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... November 6, 2017 due to his appointment as President and CEO of Sarepta Therapeutics earlier this year. "I'm pleased to welcome Dr. Mansukani to the ...
... Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... CAMBRIDGE, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
... for DMD -- CAMBRIDGE, Mass., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development ...
Subscribe now for full coverage on Sarepta Therapeutics, Inc.
Start My Free Trial